Filed: 11/12/2025ACC: 0001053906-25-000012
📋 What this filing means
ARTAL GROUP S.A. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $758.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$758.22M
Total AUM (reported)
145.69M
Total Shares
Allocation by class
COM$574.38M75.8%
COM NEW$183.84M24.2%
Portfolio Concentration
Top 3$758.22M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 145.69M
Sole
Full voting authority
145.69M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Cava Group Inc
DFNDShares9.51M
TypeSH
Market value$574.38M
75.75%
Sole
9.51M
Shared
0.00
None
0.00
Lexicon Pharmaceuticals Inc
DFNDShares136.18M
TypeSH
Market value$183.84M
24.25%
Sole
136.18M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Cava Group IncDFND | COM | 9.51M | SH | $574.38M 75.75% | 9.51M | 0.00 | 0.00 |
Lexicon Pharmaceuticals IncDFND | COM NEW | 136.18M | SH | $183.84M 24.25% | 136.18M | 0.00 | 0.00 |